← Back to Analyst Consensus 
COCP Buy
Cocrystal Pharma, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 20, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $6 | 44% |
| Jan 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Apr 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Mar 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jan 3, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Dec 4, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Oct 4, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Aug 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Aug 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jun 2, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| May 24, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Jan 24, 2023 | HC Wainwright & Co. | maintain | — → Buy | $35 | 44% |
| Nov 7, 2022 | HC Wainwright & Co. | maintain | — → Buy | $42 | 44% |
Price Target Trend
Apr 2, 2026 Oct 26, 2026
EPS Estimates
+1y —
+1q —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days